相关实验视频

Updated: Jun 6, 2025

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

⁶⁸Ga标有Olmutinib:设计,合成和评估一种新的PET EGFR探针

Hua Cheng¹, Liyan Bai², Xi Zhang³

¹Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.

Bioorganic chemistry

|November 23, 2024

概括

研究人员开发了Ga标记的Olmutinib,一种新的PET成像追踪器. 这种追踪器显示出有望通过向具有高EGFR水平的瘤来检测表皮生长因子受体 (EGFR) 阳性癌症.

科学领域:

核医学是一种核医学.
在瘤学瘤学.
放射化学放射化学是指辐射化学.

背景情况:

放射性标记的氨酸激酶抑制剂 (TKI) 对EGFR阳性癌症的分子成像至关重要.
现有的使用DOTA的Ga标记小分子探针显示瘤特异性吸收有限.

研究的目的:

使用第三代EGFR共价抑制剂Olmutinib开发一种用于EGFR阳性瘤的新型PET成像追踪器.
评估Ga-DOTA-Olmutinib作为用于检测EGFR阳性癌症的PET追踪剂的疗效.

主要方法:

通过五步过程合成DOTA-Olmutinib前体.
用Ga进行放射性标记以产生Ga-DOTA-Olmutinib.
在体外和体内稳定性评估,对EGFR水平的西部斑分析,细胞吸收实验和PET/CT成像.

主要成果:

Ga-DOTA-Olmutinib表现出中度的脂友性 (log P = 0.85) 和高稳定性.
在具有高EGFR水平的瘤细胞中观察到增强的吸收,证实了特异性.
PET/CT成像显示了显著的瘤吸收 (注射后60分钟的ID/g为4%).

结论:

标有Ga标签的Olmutinib显示了作为检测EGFR阳性癌症的PET追踪剂的潜力.
虽然有希望,但需要进一步优化以改善瘤吸收水平.

关键词:

(68) 标有Ga的标签奥尔穆提尼布 (Olmutinib) 是一种在这里,PET是PET.无线电联盟的成员.放射学成像成像放射学成像成像综合合成综合合成追踪器是一种追踪器.

更多相关视频

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging

Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging

Published on: November 20, 2018

Determining Binding Affinity KD of Radiolabeled Antibodies to Immobilized Antigens

Determining Binding Affinity KD of Radiolabeled Antibodies to Immobilized Antigens

Published on: June 23, 2022

相关概念视频

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...